国内外血站分离血浆利用概况  

Reviews on recovered plasma from non-remunerated whole blood donation system in China and abroad

作　　者：王娅[1] 李长清[1] 杨汇川 刘忠[1] 

机构地区：[1]中国医学科学院北京协和医学院输血研究所,四川成都610052 [2]成都蓉生药业有限责任公司

出　　处：《中国输血杂志》2014年第10期1068-1071,共4页Chinese Journal of Blood Transfusion

摘　　要：目前我国血液制品生产用原料血浆严重紧缺,而血站富余分离血浆无法进行再利用而面临报废的困境,宝贵的血液资源未能得到有效的综合利用。而很多国家和地区均采用自行加工或委托加工等方式将血站分离血浆用于血液制品生产。本文总结了国内外血站分离血浆的利用概况,可对我国血站富余分离血浆在满足临床需求的前提下用于血液制品生产提供参考。Continuous shortage of source plasma for fractionation has historically been a major obstacle to reach national self-sufficiency of plasma products in China. On the other hand, the recovered plasma generated from non-remunerated whole blood donations has been facing challenges of being discardea as useless products, leading to wastage of valuable blood resources. This article reviews the current situation and perspectives of recovered plasma utilizations in developed countries, in order to raise awareness of the role of recovered plasma as a starting material supplement for fractionation in meeting clinical needs in China.

关 键 词：分离血浆 原料血浆 血站 血液制品生产 

分 类 号：R457.12[医药卫生—治疗学]